| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7507295 | Drug and Alcohol Dependence | 2014 | 4 Pages |
Abstract
(1) Findings failed to support the existence of a dose-response relationship between maternal buprenorphine dose at delivery and any of 10 neonatal clinical outcomes, including NAS severity and (2) that infants treated for NAS had a higher mean NAS peak score and, spent a longer time in the hospital than did the group not treated for NAS is unsurprising.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Hendrée E. Jones, Erin Dengler, Anna Garrison, Kevin E. O'Grady, Carl Seashore, Evette Horton, Kim Andringa, Lauren M. Jansson, John Thorp,